United States Nonalcoholic Fatty Liver Disease Market Research Report Forecast 2017-2021

June 2017 | 130 pages | ID: UDB46ADC433EN
S&P Consulting

Abstracts

The United States Nonalcoholic Fatty Liver Disease Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Nonalcoholic Fatty Liver Disease industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Nonalcoholic Fatty Liver Disease market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International

United States Nonalcoholic Fatty Liver Disease Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Nonalcoholic Fatty Liver Disease Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 NONALCOHOLIC FATTY LIVER DISEASE MARKET OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease
1.2 Nonalcoholic Fatty Liver Disease Market Segmentation by Type
  1.2.1 United States Production Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Nonalcoholic Fatty Liver Disease Market Segmentation by Application
  1.3.1 Nonalcoholic Fatty Liver Disease Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nonalcoholic Fatty Liver Disease (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON NONALCOHOLIC FATTY LIVER DISEASE INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE MARKET COMPETITION BY MANUFACTURERS

3.1 United States Nonalcoholic Fatty Liver Disease Production and Share by Manufacturers (2015 and 2016)
3.2 United States Nonalcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Nonalcoholic Fatty Liver Disease Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Nonalcoholic Fatty Liver Disease Manufacturing Base Distribution, Production Area and Product Type
3.5 Nonalcoholic Fatty Liver Disease Market Competitive Situation and Trends
  3.5.1 Nonalcoholic Fatty Liver Disease Market Concentration Rate
  3.5.2 Nonalcoholic Fatty Liver Disease Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Nonalcoholic Fatty Liver Disease Production and Market Share by Type (2012-2017)
4.2 United States Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
4.3 United States Nonalcoholic Fatty Liver Disease Price by Type (2012-2017)
4.4 United States Nonalcoholic Fatty Liver Disease Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE MARKET ANALYSIS BY APPLICATION

5.1 United States Nonalcoholic Fatty Liver Disease Consumption and Market Share by Application (2012-2017)
5.2 United States Nonalcoholic Fatty Liver Disease Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURERS ANALYSIS

6.1 Conatus Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Daewoong Pharmaceutical
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Galmed International
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Kyorin Pharmaceutical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Metabolic Solutions Development
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Novartis AG
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Phenex Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Raptor Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 TCM Biotech International
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURING COST ANALYSIS

7.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE MARKET FORECAST (2017-2021)

11.1 United States Nonalcoholic Fatty Liver Disease Production, Revenue Forecast (2017-2021)
11.2 United States Nonalcoholic Fatty Liver Disease Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Nonalcoholic Fatty Liver Disease Production Forecast by Type (2017-2021)
11.4 United States Nonalcoholic Fatty Liver Disease Consumption Forecast by Application (2017-2021)
11.5 Nonalcoholic Fatty Liver Disease Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nonalcoholic Fatty Liver Disease
Table Classification of Nonalcoholic Fatty Liver Disease
Figure United States Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Table Application of Nonalcoholic Fatty Liver Disease
Figure United States Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015
Figure United States Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
Figure United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Table United States Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016)
Table United States Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Table United States Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016)
Table United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table United States Market Nonalcoholic Fatty Liver Disease Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nonalcoholic Fatty Liver Disease Average Price of Key Manufacturers in 2015
Figure Nonalcoholic Fatty Liver Disease Market Share of Top 3 Manufacturers
Figure Nonalcoholic Fatty Liver Disease Market Share of Top 5 Manufacturers
Table United States Nonalcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Sales Share by Type (2012-2017)
Figure United States Nonalcoholic Fatty Liver Disease Sales Market Share by Type in 2015
Table United States Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Price by Type (2012-2017)
Figure United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Sales Market Share by Application (2012-2017)
Figure United States Nonalcoholic Fatty Liver Disease Sales Market Share by Application in 2015
Table United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2012-2017)
Figure United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2012-2017)
Table Conatus Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table Galmed International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Galmed International Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table Galmed International Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table TCM Biotech International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2012-2017)
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure United States Nonalcoholic Fatty Liver Disease Production and Growth Rate Forecast (2017-2021)
Figure United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Table United States Nonalcoholic Fatty Liver Disease Production Forecast by Type (2017-2021)
Table United States Nonalcoholic Fatty Liver Disease Consumption Forecast by Application (2017-2021)